Nonalcoholic fatty liver disease (NAFLD) is now the most common liver disease in the
United States, with more than 80 million Americans affected. It represents a spectrum of …

Nonalcoholic fatty liver disease (NAFLD) is a clinical diagnosis that includes the presence of
5% or more hepatic steatosis as determined by liver imaging or biopsy in the absence of …

Estimates of people suffering from overweight (one billion) and obesity (300 million) are
increasing. The accumulation of triglycerides in the liver, in the absence of excess alcohol …

An increase in the prevalence of obesity and diabetes mellitus has been associated with the
rise in nonalcoholic fatty liver disease (NAFLD). Two-thirds of the obese and diabetic …

Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic fat
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …

Nonalcoholic fatty liver disease (NAFLD) increasingly is recognized as a common cause of
chronic liver disease in the United States. NAFLD spans a spectrum of clinicopathologic …

Nonalcoholic fatty liver disease (NAFLD) is known as the most common chronic liver
disease in the United States. 1 With the advent of effective antiviral therapy for hepatitis C …

Nonalcoholic fatty liver disease (NAFLD) is a common complication of obesity and type 2
diabetes mellitus (T2DM). Most times it is an unrecognized comorbidity to the primary care …

Nonalcoholic fatty liver disease (NAFLD) is easily the most common cause of chronic liver
disease in the United States (US) as the hepatic manifestation of the metabolic syndrome …

Non-alcoholic fatty liver disease (NAFLD) has emerged as the most common liver disorder
worldwide mainly attributed to the epidemic spread of obesity and type 2 diabetes mellitus …